Monday, 16 Sep 2019

You are here

Does Cirrhosis Increase the Risk of Autoimmune Disorders?

A Danish nationwide healthcare registry was used to identify newly diagnosed alcoholic cirrhosis patients between 1977 and 2010. A matched cohort analysis compared each patient with five random individuals from the population. Of the 24,679 patients diagnosed with alcoholic cirrhosis, 532 developed an autoimmune disease, with an adjusted incidence rate ratio 1.36 (95%;CI, 1.24-1.50). The strongest associations were seen with Addison's disease (aIRR = 2.47), inflammatory bowel disease (aIRR = 1.56), celiac disease (aIRR = 5.12), pernicious anemia (aIRR = 2.35), and psoriasis (aIRR = 4.06). There was no increase noted for rheumatoid arthritis (aIRR = 0.89) and the rate was lower for polymyalgia rheumatica (aIRR = 0.47; 95% CI, 0.33-0.67).

Add new comment

More Like This

Riociguat Fails in Systemic Sclerosis-Associated Digital Ulcers

Riociguat is an oral, selective soluble guanylate cyclase stimulator that has been studied in patients with digital ulcers (DU) due to systemic sclerosis (SSc) but study results show that short term (16 weeks) riociquat therapy does not sufficiently reduce the DU burden in SSc patients.

Nintedanib FDA Approved for Scleroderma Lung Disease

Last Friday, the US Food and Drug Administration approved Ofev (nintedanib) to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, called SSc-ILD. ILD as a complication of SSc may lead to progressive loss of lung function and may be associated with a significant mortality risk. Prior to the approval of Olev, there were no FDA approved drugs for SSc-ILD.

With Autoimmunity, Checkpoint Inhibitors Can Be Used

Among patients with pre-existing autoimmune diseases who developed cancer and were treated with immune checkpoint inhibitors (ICI), flares of the underlying disease and other immune-related adverse events were common, a retrospective study conducted in France showed.

New EULAR/ACR Classification Criteria for SLE

The European League Against Rheumatism (EULAR) and the American College of Rheumatology (ACR) have jointly developed new classification criteria for systemic lupus erythematosus (SLE); prompted by the need for criteria that were both highly sensitive and specific. The net result is improved sensitivity and specificity, but the use of positive ANA requirement along with a longer list of weighted criteria ensures its utility in SLE research (including early or latent SLE), but not clinical practice.

Sjogren's Syndrome at Risk for Psychiatric Disorders

A population-based claims study from Taiwan shows significantly increased incidences of depressive disorder, anxiety disorder, and sleep disorder in patients with primary Sjögren’s syndrome (pSS).